Literature DB >> 19857385

New concepts in understanding genital herpes.

Joshua T Schiffer1, Lawrence Corey.   

Abstract

Herpes simplex virus (HSV)-2 is a lifelong infection that causes recurrent genital ulcers and, rarely, disseminated and visceral disease. HSV-1 infection is an increasingly important cause of genital ulcers. HSV infections are the most common cause of genital ulcers in adults, but acquisition and chronic infection are more commonly asymptomatic than symptomatic. Both the symptomatic and asymptomatic forms of HSV are of clinical consequence for several reasons. HSV-2 infection enhances HIV-1 acquisition and transmission. In addition, sexual and perinatal transmission can occur during asymptomatic viral shedding. Perinatal transmission is of particular concern because neonatal HSV infection results in severe morbidity to the newborn. Antiviral medicines are effective for limiting recurrence duration and decreasing transmission likelihood, although no available intervention completely prevents transmission. This fact highlights the importance of laboratory diagnostics for this lifelong infection, and the need for an HSV vaccine.

Entities:  

Year:  2009        PMID: 19857385      PMCID: PMC2804398          DOI: 10.1007/s11908-009-0066-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  54 in total

1.  Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus.

Authors:  T B Martins; R D Woolstenhulme; T D Jaskowski; H R Hill; C M Litwin
Journal:  Am J Clin Pathol       Date:  2001-02       Impact factor: 2.493

2.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples.

Authors:  D I Bernstein; M A Lovett; Y J Bryson
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

4.  Maternal death secondary to disseminated herpesvirus hominis.

Authors:  T Kobbermann; L CLark; W T Griffin
Journal:  Am J Obstet Gynecol       Date:  1980-07-15       Impact factor: 8.661

5.  The relationship between condom use and herpes simplex virus acquisition.

Authors:  Anna Wald; Andria G M Langenberg; Elizabeth Krantz; John M Douglas; H Hunter Handsfield; Richard P DiCarlo; Adaora A Adimora; Allen E Izu; Rhoda Ashley Morrow; Lawrence Corey
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

6.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

7.  Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.

Authors:  Rhonda Y Kropp; Thomas Wong; Louise Cormier; Allison Ringrose; Sandra Burton; Joanne E Embree; Marc Steben
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

8.  Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.

Authors:  Catherine M Crespi; William G Cumberland; Anna Wald; Lawrence Corey; Sally Blower
Journal:  Sex Transm Infect       Date:  2007-05-02       Impact factor: 3.519

9.  The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.

Authors:  Moira A McMahon; Janet D Siliciano; Jun Lai; Jun O Liu; James T Stivers; Robert F Siliciano; Rahul M Kohli
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more
  22 in total

1.  Linear trends over 20 years in sexually transmitted infections among patients attending a tertiary care center in north Kerala, India.

Authors:  Archana Suresh; Reeshma Jose; Sarita Sasidharanpillai; Anuradha Thalian Chathoth; Kidangazhiathmana Ajithkumar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-04-12       Impact factor: 2.545

2.  Genital herpes stigma: Toward the Measurement and Validation of a highly prevalent yet hidden public health problem.

Authors:  Katie Wang; Abigail Merin; H Jonathon Rendina; John E Pachankis
Journal:  Stigma Health       Date:  2016-11-10

3.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 4.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

5.  Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.

Authors:  Tina M Cairns; Zhen-Yu Huang; John R Gallagher; Yixin Lin; Huan Lou; J Charles Whitbeck; Anna Wald; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

Review 6.  CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?

Authors:  Harshana S De Silva Feelixge; Daniel Stone; Pavitra Roychoudhury; Martine Aubert; Keith R Jerome
Journal:  ACS Infect Dis       Date:  2018-03-21       Impact factor: 5.084

7.  Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D.

Authors:  J Charles Whitbeck; Zhen-Yu Huang; Tina M Cairns; John R Gallagher; Huan Lou; Manuel Ponce-de-Leon; Robert B Belshe; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

Review 8.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

9.  Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study.

Authors:  Amir Hossein Mohseni; Sedigheh Taghinezhad-S; Hossein Keyvani; Narges Ghobadi
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

10.  Genotypic Characterization of Herpes Simplex Virus Type 1 Isolates in Immunocompromised Patients in Rio de Janeiro, Brazil.

Authors:  Amanda Perse da Silva; Amanda de Oliveira Lopes; Yasmine Rangel Vieira; Adilson José de Almeida; Fernando Samuel Sion; Beatriz Grinsztejn; Sandra Wagner; Vanessa Salete de Paula
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.